In adult glioblastoma, introduction of combined chemoradiotherapy of concomitant and adjuvant temozolomide (TMZ) and radiotherapy has provided a modest survival benefit [5], particularly in patients with an epigenetically silenced O6-methylguanine-DNA-methyltransferase (MGMT) gene [6]. The gene discussed is MGMT; the disease is glioblastoma.